Literature DB >> 16117695

Case report: association of combined nonarteritic anterior ischemic optic neuropathy (NAION) and obstruction of cilioretinal artery with overdose of Viagra.

Raj Akash1, Das Hrishikesh, Paul Amith, Stafanous Sabah.   

Abstract

AIMS: We report on a case of combined nonarteritic anterior ischemic optic neuropathy (NAAION) and cilioretinal artery occlusion resulting from misuse of sildenafil citrate (Viagra Pfizer Pharmaceuticals, New York, NY).
DESIGN: This is an observational case report.
METHODS: A 54-year-old white man developed blindness in his left eye after an overdose of Viagra. He was examined and fully evaluated.
RESULTS: Ocular examinations revealed a left relative afferent pupillary defect and a left combined NAAION and obstruction of the ipsilateral cilioretinal artery.
CONCLUSIONS: Although ocular side-effects of Viagra are rare, they are potentially blinding. Patients should be warned about the side-effects and against misuse of this agent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16117695     DOI: 10.1089/jop.2005.21.315

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  4 in total

Review 1.  Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction.

Authors:  Sharon A Huang; Janette D Lie
Journal:  P T       Date:  2013-07

2.  Non-arteritic anterior ischemic optic neuropathy with Cilioretinal artery occlusion: a case report.

Authors:  Ya-Yun Yang; Ming-Shan He
Journal:  BMC Ophthalmol       Date:  2019-11-14       Impact factor: 2.209

3.  Central Retinal Artery Occlusion Associated with Sildenafil Overdose.

Authors:  Mojtaba Abrishami; Seyedeh Maryam Hosseini; Hamid Mohseni; Majid Razavi; Amir Ghaffarian Mashhadi Nejad; Mohammad Baghi Yazdi; Ghodsieh Zamani
Journal:  Case Rep Ophthalmol Med       Date:  2021-09-04

4.  Case Report: Central retinal artery occlusion following sildenafil intake.

Authors:  Anis Mahmoud; Fatma Abid; Molka Khairallah; Fatma Sakji; Hassen Ibn Hadj Amor; Hala Attia; Sameh Mbarek; Riadh Messaoud
Journal:  F1000Res       Date:  2022-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.